Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer.
This report aims to provide a comprehensive presentation of the global market for Peptide Based Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Based Cancer Therapeutics. This report contains market size and forecasts of Peptide Based Cancer Therapeutics in global, including the following market information:
Global Peptide Based Cancer Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Peptide Based Cancer Therapeutics market was valued at US$ 10360 million in 2022 and is projected to reach US$ 17690 million by 2029, at a CAGR of 8.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Goserelin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Peptide Based Cancer Therapeutics include Pfizer, AstraZeneca, Johnson & Johnson, Abbott Laboratories, Allergan, AbbVie, Bausch Health and Takeda Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Peptide Based Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide Based Cancer Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Peptide Based Cancer Therapeutics Market Segment Percentages, by Type, 2022 (%)
Goserelin
Bortezomib
leuprorelin
Others
Global Peptide Based Cancer Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Peptide Based Cancer Therapeutics Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Peptide Based Cancer Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Peptide Based Cancer Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide Based Cancer Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Peptide Based Cancer Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
AstraZeneca
Johnson & Johnson
Abbott Laboratories
Allergan
AbbVie
Bausch Health
Takeda Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peptide Based Cancer Therapeutics, market overview.
Chapter 2: Global Peptide Based Cancer Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Peptide Based Cancer Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peptide Based Cancer Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Peptide Based Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptide Based Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peptide Based Cancer Therapeutics Overall Market Size
2.1 Global Peptide Based Cancer Therapeutics Market Size: 2022 VS 2029
2.2 Global Peptide Based Cancer Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peptide Based Cancer Therapeutics Players in Global Market
3.2 Top Global Peptide Based Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Peptide Based Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Peptide Based Cancer Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Peptide Based Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peptide Based Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Peptide Based Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Peptide Based Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Peptide Based Cancer Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Goserelin
4.1.3 Bortezomib
4.1.4 leuprorelin
4.1.5 Others
4.2 By Type - Global Peptide Based Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Peptide Based Cancer Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Peptide Based Cancer Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Peptide Based Cancer Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peptide Based Cancer Therapeutics Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Peptide Based Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Peptide Based Cancer Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Peptide Based Cancer Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Peptide Based Cancer Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Peptide Based Cancer Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Peptide Based Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Peptide Based Cancer Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Peptide Based Cancer Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Peptide Based Cancer Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Peptide Based Cancer Therapeutics Revenue, 2018-2029
6.3.2 US Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.3.3 Canada Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.3.4 Mexico Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Peptide Based Cancer Therapeutics Revenue, 2018-2029
6.4.2 Germany Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.4.3 France Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.4.4 U.K. Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.4.5 Italy Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.4.6 Russia Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.4.8 Benelux Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Peptide Based Cancer Therapeutics Revenue, 2018-2029
6.5.2 China Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.5.3 Japan Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.5.4 South Korea Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.5.6 India Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Peptide Based Cancer Therapeutics Revenue, 2018-2029
6.6.2 Brazil Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.6.3 Argentina Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Peptide Based Cancer Therapeutics Revenue, 2018-2029
6.7.2 Turkey Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.7.3 Israel Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Peptide Based Cancer Therapeutics Market Size, 2018-2029
6.7.5 UAE Peptide Based Cancer Therapeutics Market Size, 2018-2029
7 Peptide Based Cancer Therapeutics Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Peptide Based Cancer Therapeutics Major Product Offerings
7.1.4 Pfizer Peptide Based Cancer Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Peptide Based Cancer Therapeutics Major Product Offerings
7.2.4 AstraZeneca Peptide Based Cancer Therapeutics Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Peptide Based Cancer Therapeutics Major Product Offerings
7.3.4 Johnson & Johnson Peptide Based Cancer Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Peptide Based Cancer Therapeutics Major Product Offerings
7.4.4 Abbott Laboratories Peptide Based Cancer Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Abbott Laboratories Key News & Latest Developments
7.5 Allergan
7.5.1 Allergan Company Summary
7.5.2 Allergan Business Overview
7.5.3 Allergan Peptide Based Cancer Therapeutics Major Product Offerings
7.5.4 Allergan Peptide Based Cancer Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Allergan Key News & Latest Developments
7.6 AbbVie
7.6.1 AbbVie Company Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Peptide Based Cancer Therapeutics Major Product Offerings
7.6.4 AbbVie Peptide Based Cancer Therapeutics Revenue in Global Market (2018-2023)
7.6.5 AbbVie Key News & Latest Developments
7.7 Bausch Health
7.7.1 Bausch Health Company Summary
7.7.2 Bausch Health Business Overview
7.7.3 Bausch Health Peptide Based Cancer Therapeutics Major Product Offerings
7.7.4 Bausch Health Peptide Based Cancer Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Bausch Health Key News & Latest Developments
7.8 Takeda Pharmaceutical
7.8.1 Takeda Pharmaceutical Company Summary
7.8.2 Takeda Pharmaceutical Business Overview
7.8.3 Takeda Pharmaceutical Peptide Based Cancer Therapeutics Major Product Offerings
7.8.4 Takeda Pharmaceutical Peptide Based Cancer Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Takeda Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Peptide Based Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Peptide Based Cancer Therapeutics Market Drivers in Global Market
Table 3. Peptide Based Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Peptide Based Cancer Therapeutics in Global Market
Table 5. Top Peptide Based Cancer Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Peptide Based Cancer Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Peptide Based Cancer Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Peptide Based Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Peptide Based Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peptide Based Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Peptide Based Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Peptide Based Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Peptide Based Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Peptide Based Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Peptide Based Cancer Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Peptide Based Cancer Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Peptide Based Cancer Therapeutics Product Offerings
Table 32. Pfizer Peptide Based Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. AstraZeneca Company Summary
Table 35. AstraZeneca Peptide Based Cancer Therapeutics Product Offerings
Table 36. AstraZeneca Peptide Based Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca Key News & Latest Developments
Table 38. Johnson & Johnson Company Summary
Table 39. Johnson & Johnson Peptide Based Cancer Therapeutics Product Offerings
Table 40. Johnson & Johnson Peptide Based Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson & Johnson Key News & Latest Developments
Table 42. Abbott Laboratories Company Summary
Table 43. Abbott Laboratories Peptide Based Cancer Therapeutics Product Offerings
Table 44. Abbott Laboratories Peptide Based Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Abbott Laboratories Key News & Latest Developments
Table 46. Allergan Company Summary
Table 47. Allergan Peptide Based Cancer Therapeutics Product Offerings
Table 48. Allergan Peptide Based Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Allergan Key News & Latest Developments
Table 50. AbbVie Company Summary
Table 51. AbbVie Peptide Based Cancer Therapeutics Product Offerings
Table 52. AbbVie Peptide Based Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. AbbVie Key News & Latest Developments
Table 54. Bausch Health Company Summary
Table 55. Bausch Health Peptide Based Cancer Therapeutics Product Offerings
Table 56. Bausch Health Peptide Based Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Bausch Health Key News & Latest Developments
Table 58. Takeda Pharmaceutical Company Summary
Table 59. Takeda Pharmaceutical Peptide Based Cancer Therapeutics Product Offerings
Table 60. Takeda Pharmaceutical Peptide Based Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Takeda Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Peptide Based Cancer Therapeutics Segment by Type in 2022
Figure 2. Peptide Based Cancer Therapeutics Segment by Application in 2022
Figure 3. Global Peptide Based Cancer Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Peptide Based Cancer Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Peptide Based Cancer Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Peptide Based Cancer Therapeutics Revenue in 2022
Figure 8. By Type - Global Peptide Based Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Peptide Based Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Peptide Based Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Peptide Based Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Peptide Based Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Peptide Based Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Peptide Based Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Peptide Based Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Peptide Based Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Peptide Based Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Peptide Based Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Peptide Based Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca Peptide Based Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson & Johnson Peptide Based Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Abbott Laboratories Peptide Based Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Allergan Peptide Based Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AbbVie Peptide Based Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bausch Health Peptide Based Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Takeda Pharmaceutical Peptide Based Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
